The mission of the Center for Neurodegenerative Disease Research (CNDR) is to promote and conduct multidisciplinary clinical and basic research to increase the understanding of the causes and mechanisms leading to brain dysfunction and degeneration in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body dementia (LBD), Frontotemporal degeneration (FTD), Amyotrophic lateral sclerosis (ALS), Primary lateral sclerosis (PLS), Motor neuron disease (MND), and related disorders that occur increasingly with advancing age. Implicit in the mission of the CNDR are two overarching goals: 1.) Find better ways to cure and treat these disorders, 2. Provide training to the next generation of scientists.
View ResourceCenter for Neuroengineering and Therapeutics
The Center is working to develop and test new devices that can restore brain and nervous system function after it has been lost to disease or disability.
View ResourceCenter for Neuroscience and Society
The Center is a group of faculty and students from departments spanning the Schools of Arts and Sciences, Medicine, Law, Wharton and Engineering and Applied Science at the University of Pennsylvania, whose work addresses the ethical, legal and social implications of neuroscience.
View ResourceCenter on Alpha-Synuclein Strains in Alzheimer’s Disease and Related Dementias
The U19 Center and Penn biosample bank that the Penn team has developed over the past 20 years will be a valuable resource to other investigators beyond Penn who pursue research on amyloid polymorphisms and strain. The Penn U19 Center innovates by elucidating mechanisms underlying the heterogeneous progression of cognitive impairment to dementia in LBD compared to AD+aSyn in addition to neurodegeneration mediated by progressive accumulation and cell-to-cell spread of pathological aSyn strains. Thus, the Penn U19 Center seeks to understand the molecular mechanisms that underlie AD+aSyn/LBD heterogeneity.
View ResourceFrontotemporal Degeneration Center (FTDC)
The Penn Frontotemporal Degeneration Center brings together an energetic team of creative clinicians and researchers dedicated to the investigation and treatment of early onset neurodegenerative conditions. The research expertise at the Penn FTD Center spans many levels of neuroscience ranging from detailed clinico-pathological studies, biomarker discovery, genetics, neuropsychological studies, functional and structural neuroimaging, and cognitive neuroscience investigations of language, memory, and social cognition.
View ResourceHome Care Suite
The Home Care Suite is an actual home environment within the Helene Fuld Pavilion for Innovative Learning and Simulation in the University of Pennsylvania School of Nursing, serving as a platform to facilitate new ideas and tools for processes and systems that promote health and wellness, disease prevention and management in the home/ community setting across the lifespan. Within this space (that is built as a studio apartment) various technologies are installed (for short or long term) and pilot-tested. The goal is to accelerate design and testing of innovative health solutions in the home recognizing that simulated environments yield more unique responses and drive better explorations about prototypes and solutions.
View ResourceInstitute for Biomedical Informatics (IBI)
The IBI provides leadership, education, and critical infrastructure to advance the integration and application of informatics methods and software in biomedical research including studies of common neuropsychiatric diseases such as depression, anxiety, stroke, and dementia.
View ResourceLeonard Davis Institute of Health Economics (Penn LDI)
The mission of Penn LDI is to achieve effective and efficient health care for all people by supporting collaborative, interdisciplinary, cutting-edge research, and education. As Penn’s hub for health care delivery, health policy, and population health, the LDI connects and amplifies over 500 Fellows across the University, and trains the next generation of researchers.
View ResourceMahoney Institute for Neurosciences
Founded as the Institute of Neurological Sciences in 1953 by the visionary professor of Anatomy, Dr. Louis Flexner, our Institute was renamed in 1985 to reflect the keen interest and support that corporate magnate David Mahoney brought to neuroscience. MINS founded and continues to provide substantial support for the Neuroscience Graduate Group (NGG), Penn’s award-winning doctoral program in neuroscience.
View ResourceNewCourtland Center for Transitions and Health
The mission of the Center is to influence, via rigorous evidence, practices and policies designed to enhance transitions in health and healthcare, improve health and quality of life outcomes and promote wiser use of resources for the growing population of chronically ill adults in the U.S. and globally.
View Resource